Response of tumour cells to hypoxia: role of p53 and NFkB.

Hypoxia is present in several areas of malignant tumours and is thought to result from an inadequate rate of tumour angiogenesis, vascular collapse, or both. The presence and extent of these hypoxic tumour microenvironments have recently been shown to influence tumour progression by regulating both tumour cell survival and the expression of key angiogenic molecules. Recent studies have suggested that mutations in the tumour suppressor gene, p53, may play an important role in regulating the adaptive response of tumour cells to hypoxia by enhancing their survival and release of proangiogenic factors such as vascular endothelial growth factor. It has even been suggested that hypoxia may select for the survival of the more malignant clones harbouring such genetic defects as mutations in p53. Recently, the transcription factor, NFkB, has also been implicated as a novel mediator of the effects of hypoxia and reoxygenation in tumour cells. This article reviews some of the molecular mechanisms subserving the responses of tumour cells to hypoxic stress, particularly the role and relation of NFkB and p53 in regulating this phenomenon.

[1]  C. Mueller-Dieckmann,et al.  Tyrosine Phosphorylation of IkB-a Activates NF-kB without Proteolytic Degradation of IkB-a , 1996 .

[2]  M. Rocchi,et al.  Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. , 1996, Circulation.

[3]  A. Ding,et al.  Macrophages derived from C3H/HeJ (Lpsd ) mice respond to bacterial lipopolysaccharide by activating NF‐χB , 1995, Journal of leukocyte biology.

[4]  G. Semenza,et al.  p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene. , 1997, Cancer research.

[5]  S. McKnight,et al.  Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. , 1997, Genes & development.

[6]  O. Melnyk,et al.  Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth. , 1996, Cancer research.

[7]  H. Wu,et al.  NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress. , 1994, The Journal of biological chemistry.

[8]  T. Graeber,et al.  Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status , 1994, Molecular and cellular biology.

[9]  M. Matsumoto,et al.  Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Milner,et al.  Specific DNA binding by different classes of human p53 mutants. , 1995, Oncogene.

[11]  D. Mukhopadhyay,et al.  Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. , 1995, Cancer research.

[12]  L. Crawford,et al.  Characterization of the human p53 gene promoter , 1989, Molecular and cellular biology.

[13]  Anthony J. Guidi,et al.  Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. , 1995, Human pathology.

[14]  K. Dameron,et al.  Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. , 1994, Science.

[15]  N. Sonenberg,et al.  Disruption of I kappa B alpha regulation by antisense RNA expression leads to malignant transformation. , 1994, Oncogene.

[16]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[17]  J. Folkman,et al.  TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATION , 1972, The Journal of experimental medicine.

[18]  G. Semenza,et al.  A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation , 1992, Molecular and cellular biology.

[19]  Alain Israë.  Signal transduction: IκB kinase all zipped up , 1997, Nature.

[20]  A. Giaccia,et al.  Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. , 1996, Cancer research.

[21]  D. Hanahan,et al.  Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. , 1997, Cancer research.

[22]  M. Karin,et al.  Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation , 1996, Molecular and cellular biology.

[23]  M. Jung,et al.  Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated I kappa B-alpha. , 1995, Science.

[24]  K. Alitalo,et al.  Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia , 1997, Oncogene.

[25]  C. Angeletti,et al.  Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression. , 1997, British Journal of Cancer.

[26]  R. Gallo,et al.  Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice. , 1997, Journal of immunology.

[27]  Michael Karin,et al.  Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death , 1996, Cell.

[28]  A. Koong,et al.  Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). , 1994, Cancer research.

[29]  K. Plate,et al.  Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible In vivo regulatory mechanisms , 1994, International journal of cancer.

[30]  W. Kolch,et al.  Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. , 1994, Oncogene.

[31]  P. Vaupel,et al.  The influence of tumor blood flow and microenvironmental factors on the efficacy of radiation, drugs and localized hyperthermia , 1997, Klinische Padiatrie.

[32]  D. Katz,et al.  Inhibition of NF‐kappaB/Rel induces apoptosis of murine B cells. , 1996, The EMBO journal.

[33]  A. Harris,et al.  Cytokine networks in solid human tumors: regulation of angiogenesis , 1994, Journal of leukocyte biology.

[34]  T. Graeber,et al.  Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions. , 1997, Cancer research.

[35]  Erwin G. Van Meir,et al.  Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells , 1994, Nature Genetics.

[36]  G. Semenza,et al.  Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Y Fujii-Kuriyama,et al.  A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[38]  C. Mueller-Dieckmann,et al.  Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α , 1996, Cell.

[39]  B. Aggarwal,et al.  Site-specific Tyrosine Phosphorylation of IκBα Negatively Regulates Its Inducible Phosphorylation and Degradation* , 1996, The Journal of Biological Chemistry.

[40]  A. Harris,et al.  Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. , 1995, Journal of the National Cancer Institute.

[41]  E. Lakatta,et al.  p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. , 1997, The Journal of clinical investigation.

[42]  Y. Tsujimoto,et al.  Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. , 1996, Cancer research.

[43]  Lieve Moons,et al.  Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele , 1996, Nature.

[44]  X. Sun,et al.  Identification of a novel p53 promoter element involved in genotoxic stress-inducible p53 gene expression , 1995, Molecular and cellular biology.

[45]  A. Koong,et al.  Hypoxia Causes the Activation of Nuclear Factor κB through the Phosphorylation of IκBα on Tyrosine Residues , 1994 .

[46]  M. Runge,et al.  Hypoxia Induces Cyclooxygenase-2 via the NF-κB p65 Transcription Factor in Human Vascular Endothelial Cells* , 1997, The Journal of Biological Chemistry.